Share on StockTwits
 

UnitedHealth Group (NYSE:UNH)‘s stock had its “buy” rating reiterated by TheStreet in a research note issued on Wednesday, Analyst Ratings Network reports.

The analysts wrote, “UnitedHealth Group (UNH) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.”

Shares of UnitedHealth Group (NYSE:UNH) traded down 0.13% during mid-day trading on Wednesday, hitting $75.22. The stock had a trading volume of 255,449 shares. UnitedHealth Group has a 1-year low of $52.88 and a 1-year high of $77.33. The stock has a 50-day moving average of $72.87 and a 200-day moving average of $72.37. The company has a market cap of $74.407 billion and a P/E ratio of 13.69.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Wednesday, January 15th. The company reported $1.41 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.40 by $0.01. The company had revenue of $31.10 billion for the quarter, compared to the consensus estimate of $31.06 billion. During the same quarter in the prior year, the company posted $1.20 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. On average, analysts predict that UnitedHealth Group will post $5.59 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, March 25th. Investors of record on Friday, March 14th will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 1.49%.

Other equities research analysts have also recently issued reports about the stock. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday, January 22nd. Separately, analysts at Monness Crespi & Hardt downgraded shares of UnitedHealth Group from a “neutral” rating to a “sell” rating in a research note on Tuesday, January 21st. They now have a $59.00 price target on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of UnitedHealth Group in a research note on Friday, January 17th. They now have a $76.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $78.72.

In other UnitedHealth Group news, SVP Eric Rangen unloaded 24,825 shares of the company’s stock on the open market in a transaction that occurred on Thursday, February 20th. The shares were sold at an average price of $73.60, for a total value of $1,827,120.00. Following the completion of the transaction, the senior vice president now directly owns 18,970 shares of the company’s stock, valued at approximately $1,396,192. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

UnitedHealth Group Incorporated (NYSE:UNH) diversified health and well-being company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.